MB, Levis & Associates
BMY icon

MB, Levis & Associates’s Bristol-Myers Squibb BMY Stock Holding History

MB, Levis & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$70.1K Buy
1,123
+10
+0.9% +$632 0.03% 97
2026
Q2 		$64.1K Buy
1,113
+12
+1% +$689 0.02% 97
2026
Q1 		$66.8K Buy
1,101
+12
+1% +$700 0.03% 95
2025
Q4 		$58.7K Sell
1,089
-109
-9% -$5.24K 0.02% 101
2025
Q3 		$54K Sell
1,198
-383
-24% -$17.9K 0.02% 101
2025
Q2 		$73.2K Buy
1,581
+395
+33% +$19.4K 0.03% 106
2025
Q1 		$72.4K Buy
1,186
+8
+0.7% +$466 0.03% 104
2024
Q4 		$66.6K Buy
1,178
+8
+0.7% +$447 0.03% 105
2024
Q3 		$60.5K Buy
1,170
+10
+0.9% +$469 0.03% 111
2024
Q2 		$48.2K Buy
1,160
+10
+0.9% +$447 0.03% 116
2024
Q1 		$62.4K Buy
1,150
+9
+0.8% +$458 0.03% 107
2023
Q4 		$58.6K Buy
1,141
+8
+0.7% +$420 0.03% 107
2023
Q3 		$65.8K Buy
1,133
+7
+0.6% +$429 0.04% 96
2023
Q2 		$72K Buy
1,126
+6
+0.5% +$402 0.05% 95
2023
Q1 		$77.6K Buy
1,120
+1
+0.1% +$71 0.05% 90
2022
Q4 		$80.5K Buy
+1,119
New +$84.4K 0.06% 85

Other funds holding BMY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

MB, Levis & Associates's BMY Position: Q3 2026 in Review

MB, Levis & Associates increased its Bristol-Myers Squibb (BMY) stake by 0.9% in Q3 2026, buying an estimated $632 and bringing the position to 1,123 shares worth $70.1K. The position accounts for 0.03% of the portfolio, ranked #97.

MB, Levis & Associates first reported a position in BMY in Q4 2022 and has held it in 16 quarters since. The position peaked at $80.5K in Q4 2022. 1,510 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • MB, Levis & Associates held 1,123 shares of Bristol-Myers Squibb worth $70.1K as of Q3 2026.
  • MB, Levis & Associates bought 10 Bristol-Myers Squibb shares in Q3 2026, an estimated $632.
  • Bristol-Myers Squibb made up 0.03% of MB, Levis & Associates's portfolio in Q3 2026, its #97 holding.
  • MB, Levis & Associates first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 16 quarters since.
  • MB, Levis & Associates's Bristol-Myers Squibb position peaked at $80.5K in Q4 2022.
  • 1,510 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.